View drug registration information details.
Items | Registration information |
ID | 431 |
No | 431 |
Brand Name | AVASTIN 100 MG/4 ML |
Ingredients | BEVACIZUMAB 100 MG / 4ML |
Dosage Form | SOLUTION FOR INFUSION |
Primary Packaging | VIAL |
Storage | STORE AT 2-8'C. KEEP VIAL IN THE OUTER CARTON, DO NOT FREEZE. |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 1 VIAL X 4 ML |
Dispensing Category | Prescription only |
ATC Classification | L01XC07 |
Pharmaceutical Class | ANTINEOPLASTICS |
Indications | - METASTATIC COLORECTAL CANCER
- LOCALLY RECURRENT OR METASTATIC BREAST CANCER.
- ADVANCED,METASTATIC OR RECURRENT NON SMALL CELL LUNG CANCER.
- ADVANCED AND/OR METASTATIC RENAL CELL CANCER.
- MALIGNANT GLIOMA ( WHO GRADE IV) GLIOBLASTOMA.
- EPITHELI |
Contraindications | HYPERSENSITIVITY TO ANY OF COMPONANTS OF THE PRODUCT, CHINESE HAMSTER OVARY CELL PRODUCTS OR OTHER RECOMBINATE HUMAN OR HUMANIZED ANTIBODIES. |
Side Effects | ANOREXIA, DYSGEUSIA, HEADACHE, EYE SISORDER, HYPERTENSION, DISPNEA, CONSTIPATION. |
Unit Price | - |
EDL |
No |
Description | CLEAR TO SLIGHTLY OPALESCENT, COLORLESS TO PALE BROWN |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | ROCHE DIAGNOSTICS GMBH |
Country | GERMANY |
Import Registration No | 56 922 01 |
Import Registration Date | 2012-12-04 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-12-03 |
FDD Registration No | 07 I 3868/13 |
FDD Registration Date | 2023-03-31 |
Expiry Date | 2026-03-30 |
Back to drug list
|